5++

Apollo Pharmacy is a leading retail chain of Pharmacy and is a unit of - Apollo Hospitals Enterprise Ltd. - Asia's largest healthcare group.  Our growing Retail Pharmacy network touches lives across the length and breadth of India. Accredited with - International Quality Certification, with over 30 years of retailing experience, customer-focused service and brand value our network spans out to over 3000 retail pharmacies through which we have been serving our customers for their healthcare needs 24x7.

Post : Pharmacy Training Manager

Incorporated in the year 1994, Syngene International is one of India's premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities. The state-of-the-art research facilities have been qualified by various pharmaceutical majors & regulatory agencies and has received various certifications including ISO 9001: 2008, ISO 14001:2004, OHSAS 18001:2007, GLP and AAALAC.

Post : Jr.Exe/ Asso.Exe/Exe/Sr.Exe/Jr.Mgr-Production(API)

AstraZeneca contributes meaningfully to the UK beyond the provision of our medicines and the benefits they provide to the health of the nation.
We commissioned a report in 2009 to measure our significant investment to the UK economy, which includes investment in jobs and wealth creation. Oxera, an independent economic consultancy provided the analysis for this report.
The report looks at our contribution to the UK as a whole as well as at individual countries within the UK, and at regions where AstraZeneca has a significant presence, identifying the company’s local impact in terms of spending, jobs and economic prosperity.

Post : Global Regulatory Lead - Associate Director

The United States Pharmacopeia (USP) is a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other healthcare products manufactured or sold in the United States. USP also sets widely recognized standards for food ingredients and dietary supplements. USP sets standards for the quality, purity, strength, and consistency of these products–critical to the public health. USP's standards are recognized and used in more than 130 countries around the globe. These standards have helped to ensure public health throughout the world for close to 200 years.

Post : Vice President - Site Operations

Our client, established in the year 1986, is the world’s second largest integrated manufacturer of Ephedrine and Pseudo ephedrine salts. Our client's manufacturing facility at Mahad has been audited and approved by the Australian TGA, and the US FDA.

Post : Unit Head (Sr. / GM-Operations)

Our client is a 30 year old API Mfg Co. headquartered in Mumbai

Post : General Manager- Finance & Accounts

Merck Limited was set up in India as the first Merck subsidiary in Asia in 1967.  The Company operates both its Pharmaceuticals and Chemicals businesses in the country.
Merck was also the first Merck Group Company to go public in the year 1981.  The Merck Group now holds 51% of the share capital in Merck Limited, while the remaining 49% is traded on the Bombay Stock Exchange Ltd. and National Stock Exchange of India Ltd.  Merck Specialities Pvt. Ltd., the wholly owned Indian subsidiary of Merck KGaA, was incorporated in 2005.

Post : Zonal Manager

PADMAVATHI COLLEGE OF PHARMACY & RESEARCH INSTITUTE,Dharmapuri is a unique and premier institute in Tamilnaidu.its is a Self financing institute managed by Sri Govinda Gounder Memorial Educational Trust,Dharmapuri. The institute was established in 1992 by the chairman,Mr.M.G.SEKHAR,BA.,B.L

Post : Principal

The flagship company of the Piramal Group, Piramal Enterprises Ltd. (PEL), has business interests in Pharma, Information Management, and Financial Services verticals of the group.  Towards the late 80s, we shifted our focus from textile to pharmaceuticals. We chose to invest significantly in the domestic formulation development business, while other companies in the industry concentrated on international generics. Our efforts proved successful with a track record of approximately 23% revenue CAGR. In 2010, our strategy accomplished a sale of its domestic formulations business at an unprecedented value of ~9x sales and ~30x EBITDA.